A prodrug is a compound that has negligible, or lower, activity against a specified pharmacological target than one of its major metabolites. Prodrugs can be used to improve drug delivery or pharmacokinetics, to decrease toxicity, or to target the drug to specific cells or tissues. Ester and phosphate hydrolysis are widely used in prodrug design because of their simplicity, but such approaches are relatively ineffective for targeting drugs to specific sites. The activation of prodrugs by the cytochrome P450 system provides a highly versatile approach to prodrug design that is particularly adaptable for targeting drug activation to the liver, to tumors or to hypoxic tissues
The molecular information that became available over the past two decades significantly influenced t...
The conventional old treatment method for cancer therapy is associated with severe side effects alon...
Research into advanced therapeutic materials is of growing importance worldwide, particularly in the...
Prodrugs are chemically modified derivatives introduced in therapy due to their advantageous physico...
Nowadays, improvement of physicochemical, biopharmaceutical and pharmacokinetic properties of pharma...
Prodrugs are biologically inactive derivatives of an active drug intended to solve certain problems ...
Many drugs suffer from an extensive first-pass metabolism leading to druginactivation and/or product...
Many drugs suffer from an extensive first-pass metabolism leading to drug inactivation and/or produc...
The rationale for the development of prodrugs relies upon delivery of higher concentrations of a dru...
AbstractProdrug design is an important part of drug discovery. Prodrugs can offer many advantages ov...
An ideal cancer chemotherapeutic prodrug is completely inactive until metabolized by a tumour-specif...
Prodrugs, with their capability of declining the adverse events and elevating the bioavailability of...
Prodrugs are derivatives of bioactive molecules that can become activated in vivo by a chemical or e...
Cyclophosphamide (CPA) and ifosfamide (IFA) are oxazaphos-phorine anticancer prodrugs metabolized by...
It is estimated that about 10 % of the drugs approved worldwide can be classified as prodrugs. Prodr...
The molecular information that became available over the past two decades significantly influenced t...
The conventional old treatment method for cancer therapy is associated with severe side effects alon...
Research into advanced therapeutic materials is of growing importance worldwide, particularly in the...
Prodrugs are chemically modified derivatives introduced in therapy due to their advantageous physico...
Nowadays, improvement of physicochemical, biopharmaceutical and pharmacokinetic properties of pharma...
Prodrugs are biologically inactive derivatives of an active drug intended to solve certain problems ...
Many drugs suffer from an extensive first-pass metabolism leading to druginactivation and/or product...
Many drugs suffer from an extensive first-pass metabolism leading to drug inactivation and/or produc...
The rationale for the development of prodrugs relies upon delivery of higher concentrations of a dru...
AbstractProdrug design is an important part of drug discovery. Prodrugs can offer many advantages ov...
An ideal cancer chemotherapeutic prodrug is completely inactive until metabolized by a tumour-specif...
Prodrugs, with their capability of declining the adverse events and elevating the bioavailability of...
Prodrugs are derivatives of bioactive molecules that can become activated in vivo by a chemical or e...
Cyclophosphamide (CPA) and ifosfamide (IFA) are oxazaphos-phorine anticancer prodrugs metabolized by...
It is estimated that about 10 % of the drugs approved worldwide can be classified as prodrugs. Prodr...
The molecular information that became available over the past two decades significantly influenced t...
The conventional old treatment method for cancer therapy is associated with severe side effects alon...
Research into advanced therapeutic materials is of growing importance worldwide, particularly in the...